Articles On Resonance Health (ASX:RHT)

Title Source Codes Date
Medtech Resonance Health expands global clinical trial reach with Perth-based TrialsWest acquisition

Medical technology firm Resonace Health is banking on its recent purchase of Perth-based TrialsWest to expand deeper into the global clinical trial industry.

The West RHT 1 week ago
Resonance Health to acquire TrialsWest in $8m deal, expands global clinical trial reach

Perth-based Resonance Health (ASX: RHT) has secured a deal to acquire private clinical trial site and research centre TrialsWest, representing a major step forward in its growth strategy. TrialsWest is one of Australia’s most experienced cl...

smallcapsau.mystagingwebsite.com RHT 3 weeks ago
ASX Health Winners February: Law of attrition applies but biotech is a long term game; Nyrada up 5x last month

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

Stockhead RHT 1 month ago
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Stockhead RHT 1 month ago
Closing Bell: ASX ends it like Beckham… lower and with a pretty whimper, which could still suggest good things ahead

The ASX benchmark has closed slightly lower on Friday Losses across the Energy Sector weighed Small caps led ID8   The Aussie sharemarket has ended lower on Friday, driven to a small disgrace by the ongoing declines in oil prices – down...

Stockhead RHT 5 months ago
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

Stockhead RHT 5 months ago
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

Stockhead RHT 6 months ago
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Stockhead RHT 6 months ago
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Stockhead RHT 7 months ago
Resonance Health announces the appointment of chief financial officer

Resonance Health (ASX:RHT) has announced that Benjamin Carruthers has been appointed its chief financial officer and is expected to commence the role in October.

BiotechDispatch RHT 7 months ago
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Stockhead RHT 7 months ago
Check Up: Australian biotech sector continues to be a magnet for US investors

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

Stockhead RHT 7 months ago
TMH Market Close: ASX200 finishes the week on a high

The ASX200 had a stronger session than expected, closing up, but only just. The real estate sector led the way gaining 1.8 per cent, utilities were also up by a per cent and materials just short of a per cent. In the green Goodman...

themarketherald.com.au RHT 8 months ago
In Case You Missed It: Resource tech snags the lead and a $1.55m BHP deal

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Stockhead RHT 8 months ago
TMH Spotlight: ASX edges higher, real estate leading gains

The ASX200 has gone against expectations and lifted ever so slightly by 0.1 of a per cent mid-session. Real estate led gainers – up nearly 1.5 per cent – but the heat was on communications and consumer discretionary which have both shed...

themarketherald.com.au RHT 8 months ago
ASX Health Stocks: Resonance Health jumps 22pc on global pharma contract

Resonance Health has been contracted by global pharma Sun Pharma New contract is worth $6.33m  The Contract Research Organization (CRO) market is forecasted to grow rapidly   Resonance Health (ASX:RHT), a company providing services to cli...

Stockhead RHT 8 months ago
Resonance Health (ASX:RHT) inks contract with major global pharma company

Resonance Health (RHT) is contracted by Sun Pharmaceutical Industries to provide services for its clinical trial in Australia RHT will provide clinical research organisation, laboratory analysis, and imaging services at various time poin...

themarketherald.com.au RHT 8 months ago
CLOSING BELL: Rock chips and Real Estate help keep the ASX fall to just 0.68pc for the day

The ASX grinds to a -0.68% close after another rough night on Wall Street. A late surge from the Real Estate sector saw it land on +1.11% for the day. Rock chip results dominated the Small Caps winners list – yep, it was that kinda day.  ...

Stockhead RHT 8 months ago
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

Stockhead RHT 8 months ago
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

Stockhead RHT 8 months ago
ASX Health Stocks: Invex granted orphan drug designation in Europe; Resonance has a new CEO

Invex granted orphan drug designation in Europe Resonance Health has a new CEO EBR to raise $35m as it eyes market launch   Invex Therapeutics (ASX:IXC) announced the granting of orphan drug designation (ODD) from the European Medicines A...

Stockhead RHT 10 months ago
ASX Today: Stocks to watch on Friday

Futures suggest the ASX will open lower to cap off the working week following a mixed session on Wall Street overnight. Meanwhile, oil prices plunged, sinking to below US$70 a barrel. On home soil, here are some ASX-listed companies w...

themarketherald.com.au RHT 10 months ago
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Stockhead RHT 10 months ago
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Stockhead RHT 10 months ago
ASX Biotech Winners in May: We’re finally seeing signs of life on the back of another clinical breakthrough

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

Stockhead RHT 10 months ago
Check Up: Here’s how diabetes drugs can help you get off the beers and lose weight

Pfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of these weight loss drugs? Best and worst performing ASX biotechs over the past week   Earlier this week, Pfizer surprised the market by say...

Stockhead RHT 10 months ago
Check Up Budget Edition: Which ASX healthcare stocks will reap benefits from the Budget?

The Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health and Telehealth also received significant funding allocations Here are the ASX stocks that could benefit   Medicare, telehealth and mental...

Stockhead RHT 11 months ago
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m quarterly sales

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

Stockhead RHT 11 months ago
Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Stockhead RHT 1 year ago
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

Stockhead RHT 1 year ago
Closing Bell: Blocked! ACCC says no to TPG Telecom & Telstra deal

The ASX 200 rose a tidy 1.29% today with all sectors in the green ABS releases Aussie migrant data employment outcomes for the first time  ACCC gives the thumbs down to Telstra and TPG’s merger plans   The ASX 200 gained 1.29% today and...

Stockhead RHT 1 year ago
How out of favour Biotech has a PR problem and could learn from Dr Karl

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

Stockhead RHT 1 year ago
Resonance Health (ASX:RHT) contracted for two new clinical trials

Resonance Health (RHT) is contracted to provide services for two new clinical trials addressing iron-overload disordersThe company has signed contracts with two new pharmaceutical customers to provide FerriScan, Cardiac-T2, and related anal...

themarketherald.com.au RHT 1 year ago
ASX Health Stocks: Patent updates from Cynata and Proteomics; Ramsay sees good times ahead

Cynata gets Notice of Allowance from US Patent Office Proteomics secures patent in Hong Kong Ramsay Healthcare and Avita gave solid quarterly updates Cynata and Proteomics’ patents update Cynata Therapeutics (ASX:CYP) rose 8pc this mornin...

Stockhead RHT 1 year ago
Resonance Health’s (ASX:RHT) FerriScan now available on 3T MRI scanners

Resonance Health’s (RHT) flagship product, FerriScan, is now available for use on 3T MRI scanning machines FerriScan is internationally regarded by clinicians as the “gold standard” to measure liver iron concentration for patients with iro...

themarketherald.com.au RHT 1 year ago
Market highlights and 5 ASX small caps to watch on Monday

The ASX is set to open slightly lower on Monday US social media stocks tumbled on Friday, with Snap plunging by 39% Ahead this week, US Fed’s rate decision and Australia’s June quarter CPI Local shares are set to dip on Monday, with the A...

Stockhead RHT 1 year ago
Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Stockhead RHT 1 year ago
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Stockhead RHT 1 year ago
Closing Bell: Saturday can’t come soon enough as Small Caps fight on muscle memory alone

ASX ends the week sore-arsed and red-faced Some shining glimmers of hope rise among wildly swinging small caps GUD has a ‘Guh’ moment as profit downgrade sends investors scurrying   The ASX has spent this week being led by the nose into s...

Stockhead RHT 1 year ago
Check Up: Money managers are still bullish on Healthcare; here’s what they said

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

Stockhead RHT 1 year ago
Check Up: Biotechs are going through a rough patch, but recent ASX IPOs haven’t flopped too badly

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Stockhead RHT 2 years ago
Resonance Health (ASX:RHT) strikes AI medical imaging devices agreement with CARPL.ai

Resonance Health (RHT) signs a platform integration and partnership agreement with CARPL.ai CARPL.ai is the world’s first testing and deployment platform for medical imaging AI that connects healthcare providers to third-party AI applicati...

themarketherald.com.au RHT 2 years ago
Check Up: More clinical trials and FDA funding boost. Is this the end of biotech’s woes?

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

Stockhead RHT 2 years ago
Check Up: The future of telehealth, and the best and worst performing ASX health stocks for the month

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Stockhead RHT 2 years ago
Check Up: Johnson & Johnson manoeuvre causes a stir, as CSL pulls Healthcare higher on the ASX

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

Stockhead RHT 2 years ago
Closing Bell: ASX200 falls, small caps gain, petrol set to go psycho

The S&P/ASX200 is about seven points lower on Monday after a day of choppy trade, heavily impacted by some large cap hits, like Magellan (down about 10%) and an earlier whack for the big four banks after ANZ put out a profit warning. Bu...

Stockhead RHT 2 years ago
ASX Health Stocks: Resonance gets green light in US; Althea buys German cannabis company

Medical imaging software Resonance Health (ASX:RHT) has received the green light in the US for its LiverSmart medical device, making it eligible for recognition by the US government agencies and private insurers. Resonance received confirma...

Stockhead RHT 2 years ago
Resonance Health (ASX:RHT) breaks into Chinese market

Resonance Health (RHT) contracted by Chinese company Hangzhou Zede Pharma-Tech to provide services for a clinical study into a treatment for patients with blood disorders The company says the Hangzhou Zede Pharma-Tech study will use its Fe...

themarketherald.com.au RHT 2 years ago
Closing Bell: ASX microcaps selloff extends to 13%, Nasdaq set to dive again

Local markets had a breather in the form of a mid-week public holiday, but things weren’t much better once trading recommenced on Thursday. After initially jumping by more than 1%, the ASX microcap Emerging Companies index reversed course w...

Stockhead RHT 2 years ago
Resonance Health contracted to support NASH clinical trial

Resonance Health (ASX:RHT) has been contracted to provide liver-fat quantification services for Invictus Ops, a wholly-owned subsidiary of VGI Health Technology, for its clinical study of a potential new treatment for NASH.

BiotechDispatch RHT 2 years ago